| 000 | 00827 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20250516002600.0 | ||
| 264 | 0 | _c20111123 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1742-1241 | ||
| 024 | 7 |
_a10.1111/j.1742-1241.2010.02492.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbenavoli, L | |
| 245 | 0 | 0 |
_aNon-alcoholic fatty liver disease and pharmacological options. _h[electronic resource] |
| 260 |
_bInternational journal of clinical practice _cOct 2010 |
||
| 300 |
_a1583 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 773 | 0 |
_tInternational journal of clinical practice _gvol. 64 _gno. 11 _gp. 1583 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1742-1241.2010.02492.x _zAvailable from publisher's website |
| 999 |
_c20176732 _d20176732 |
||